$12.49
0.08% yesterday
Nasdaq, Feb 04, 10:09 pm CET
ISIN
US05368M1062
Symbol
CDMO

Avid Bioservices, Inc. Stock price

$12.49
+0.13 1.05% 1M
+1.98 18.84% 6M
+0.14 1.13% YTD
+6.22 99.20% 1Y
-6.88 35.52% 3Y
+6.08 94.85% 5Y
+3.88 45.06% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+0.01 0.08%
ISIN
US05368M1062
Symbol
CDMO
Sector

Key metrics

Market capitalization $798.90m
Enterprise Value $970.80m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.45
P/S ratio (TTM) P/S ratio 5.31
P/B ratio (TTM) P/B ratio 17.83
Revenue growth (TTM) Revenue growth 6.75%
Revenue (TTM) Revenue $150.45m
EBIT (operating result TTM) EBIT $-20.38m
Free Cash Flow (TTM) Free Cash Flow $-9.68m
Cash position $35.12m
EPS (TTM) EPS $-2.39
P/E forward negative
P/S forward 4.90
EV/Sales forward 5.95
Short interest 18.40%
Show more

Is Avid Bioservices, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Avid Bioservices, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Avid Bioservices, Inc. forecast:

4x Hold
100%

Analyst Opinions

4 Analysts have issued a Avid Bioservices, Inc. forecast:

Hold
100%

Financial data from Avid Bioservices, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '24
+/-
%
150 150
7% 7%
100%
- Direct Costs 139 139
13% 13%
92%
12 12
35% 35%
8%
- Selling and Administrative Expenses 19 19
7% 7%
13%
- Research and Development Expense - -
-
-
-7.80 -7.80
1,460% 1,460%
-5%
- Depreciation and Amortization 13 13
36% 36%
8%
EBIT (Operating Income) EBIT -20 -20
109% 109%
-14%
Net Profit -152 -152
1,190% 1,190%
-101%

In millions USD.

Don't miss a Thing! We will send you all news about Avid Bioservices, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avid Bioservices, Inc. Stock News

Neutral
GlobeNewsWire
22 minutes ago
TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Converti...
Neutral
GlobeNewsWire
about one hour ago
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
Neutral
GlobeNewsWire
about one hour ago
LONDON and BOSTON and TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- GHO Capital Partners LLP ("GHO"), the European specialist investor in global healthcare, and Ampersand Capital Partners (“Ampersand”), a private equity firm specialising in growth equity investments in the life sciences and healthcare sectors, today announced the successful closing of the previously announced acquisition of...
More Avid Bioservices, Inc. News

Company Profile

Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Head office United States
CEO Nicholas Green
Employees 371
Founded 1981
Website avidbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today